Are blood based cancer screening tests ready for prime time Latest from VKPrasadLab

Really honored that we at VKPrasadLab were able to publish 60+ peer reviewed articles last year!

the CABINET study 100% NIH funded Control arm patients got placebo Was that appropriate? Plenary Session Podcast 🎙️ Sensible Medicine

I've made all 540+ publications from VKPrasadLab freely available on this website in accordance with grant and university policies. Please check it out for PDFs of 15 years of our work. Email us (via the website) if something is missing or incorrect. vkprasadlab.com/publications

Does survival still matter in oncology? In this “tribute” episode, we joined w/VKPrasadLab members: definitions, examples, solutions.. all you want to know about post-protocol care and how it can distort overall survival results! We missed you, Vinay, my friend Vinay Prasad MD MPH!

J Hes VKPrasadLab Vinay Prasad MD MPH youtu.be/izyObZwRfPo

m.youtube.com/watch?v=XwnZjl…

pubmed.ncbi.nlm.nih.gov/40986753/

theoncologyshot.com Check out my new Substack where I will be sharing analyses, thoughts, papers, and anything that I feel could be interesting, mostly related to oncology and medicine in general.

New guest post of the “Let’s get ready for ESMO 2025!” series ! By Dries Develtere “Will PSMAddition Deliver?” theoncologyshot.com/p/will-psmaddi…

Nice to see sensitivity analyses run on digitized curves. Fabio Conforti et al., in their Journal of Clinical Oncology article, seems to disagree with our conclusion after running a sensitivity analysis on the updated results of NATALEE (3 year adjuvant ribociclib in HER2-, HR+ breast cancer).

It was an honor to represent UCSF School of Medicine, VKPrasadLab at the national level and present our work (co-led with Timothée Olivier, MD) at ASCO's #ASCOQLTY25. Read more about it here: meetings.asco.org/abstracts-pres…. Thank you to the organizers Fumiko Ladd Chino, MD, FASCO & co for highlighting our work. An

Nice to finally meet in person with David J. Benjamin, MD after many collaborative works together VKPrasadLab ! Looking forward to your talk David ! #ESMO25

Wonderful to meet Timothée Olivier, MD at #ESMO25! Your work with Vinay Prasad MD MPH has been so important for how I think about evidence, bias and critical appraisal in oncology. Keep doing great work!

It’s amusing when reporters and writers do not have access to FDA information on manufacturing and sterility violations — yet make calls from the peanut gallery.

Nice words from Jeremy Long about my new "The Oncology Shot" letter.🙏 Subscribe for free for regular and unique content.

In uncontrolled settings, is the observed benefit due to the drug or to indolent tumour biology? One way to answer this question is the Iceberg Plot, a visual I conceived and we published soon after I joined the VKPrasadLab Read more about it! theoncologyshot.com/p/the-iceberg-…

Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudes sciencedirect.com/science/articl… via Adam Cifu et al

"Are fears of rising cancer in young adults exaggerated?" 👉Find the answer in this unique video! So great to have Ade Adamson, MD MPP for a live talk, followed by a fascinating Q&A with VKPrasadLab core members! Thanks, Ade 🙏 Congrats to Vishal Patel and Gil Welch who co-authored

“Whenever somebody tells you that the incidence of something is going up a lot, ask about the outcome of interest, like mortality, especially as it relates to cancer” = wise words from Ade Adamson, MD MPP at the end of Q&A after he presented: "The Rise in Early-Onset Cancer in the US